Israel Basal Insulin (Long Acting Insulin) Market (2025-2031) | Growth, Analysis, Share, Size & Revenue, Companies, Forecast, Trends, Value, Outlook, Segmentation, Competitive Landscape, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Basal Insulin (Long Acting Insulin) Market Revenues & Volume, 2021 & 2031F

3.3 Israel Basal Insulin (Long Acting Insulin) Market - Industry Life Cycle

3.4 Israel Basal Insulin (Long Acting Insulin) Market - Porter's Five Forces

3.5 Israel Basal Insulin (Long Acting Insulin) Market Revenues & Volume Share, By Products, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of diabetes in Israel

4.2.2 Growing awareness about the benefits of basal insulin in managing diabetes

4.2.3 Technological advancements in insulin delivery devices

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for insulin products

4.3.2 High cost associated with basal insulin therapy

4.3.3 Limited access to healthcare services in certain regions of Israel

6.1 Israel Basal Insulin (Long Acting Insulin) Market, By Products

6.1.1 Overview and Analysis

6.1.2 Israel Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Products, 2021- 2031F

6.1.3 Israel Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Lantus, 2021- 2031F

6.1.4 Israel Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Levemir, 2021- 2031F

6.1.5 Israel Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Tresiba, 2021- 2031F

6.1.6 Israel Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Toujeo, 2021- 2031F

6.1.7 Israel Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Basaglar, 2021- 2031F

7.1 Israel Basal Insulin (Long Acting Insulin) Market Export to Major Countries

7.2 Israel Basal Insulin (Long Acting Insulin) Market Imports from Major Countries

8.1 Patient adherence rate to basal insulin therapy

8.2 Rate of adoption of advanced insulin delivery devices

8.3 Percentage of healthcare professionals recommending basal insulin therapy

8.4 Average time taken for regulatory approval of new insulin products

8.5 Rate of growth in the number of diabetes education programs in Israel

9.1 Israel Basal Insulin (Long Acting Insulin) Market Opportunity Assessment, By Products, 2021 & 2031F

10.1 Israel Basal Insulin (Long Acting Insulin) Market Revenue Share, By Companies, 2024

10.2 Israel Basal Insulin (Long Acting Insulin) Market Competitive Benchmarking, By Operating and Technical Parameters